MMP9 and myocardial infarction: The levels of MMP9 are markedly increased in post-myocardial infarction patients, and high MMP9 is an independent predictor of 2-year adverse cardiovascular events (Webb et al., 2006; Kelly et al., 2008; Somuncu et al., 2020).